Streetbeat News

Stock Prices

GHBWF

GLASF

Cannabis company Glass House Brands Inc. has raised $10.9 million in the first tranche of its $15 million Series D preferred stock offering. The funds will be used to expand cultivation capabilities and retail footprint, with plans to open new dispensaries across California. The company expects to raise an additional $4.1 million in subsequent closings of tranches under the offering.

Portfolio Pulse from Jelena Martinovic

August 25, 2023 | 12:28 pm

AFRM

Affirm reported better-than-expected Q4 financial results and issued guidance, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 25, 2023 | 12:26 pm

MRVL

Marvell Tech reported its Q2 financial results, which led to a decrease in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 25, 2023 | 12:26 pm

WDAY

Workday Inc. reported better-than-expected Q2 financial results and raised its FY24 revenue guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 25, 2023 | 12:25 pm

IMAX

NFLX

ULTA

Several analyst forecasts were released on Friday, with price target changes for multiple companies. Notably, Raymond James lowered Ulta Beauty's price target from $600 to $550, Rosenblatt boosted IMAX's price target from $27 to $30, and Loop Capital increased Netflix's price target from $425 to $500. Other companies affected include Fidelity National Information Services, Domo, Workday, FactSet Research Systems, Dollar Tree, Ferrari, Abercrombie & Fitch, and Intuit.

Portfolio Pulse from Lisa Levin

August 25, 2023 | 12:08 pm

BTCUSD

ETHUSD

HIBB

INTU

NVDA

SPY

The Fear & Greed Index has moved to the 'Fear' zone ahead of Powell's speech. Intuit, Hibbett, and three other stocks are to be watched. Ark Invest sold Nvidia shares worth nearly $1.9M. Bitcoin's future is speculated to reach a million dollars. Coinbase delisted six cryptocurrencies. Tech giants Ericsson and Huawei renewed their patent pact in the 5G era. Amazon is in early talks with Disney for ESPN streaming partnership. Tesla's Diner-Supercharger concept in LA gets green signal. Novo Nordisk's Ozempic may be propelled to greater heights by three new markets.

Portfolio Pulse from Akanksha Bakshi

August 25, 2023 | 12:08 pm

IMVT

ROIV

XBI

Vivek Ramaswamy, a Republican presidential candidate and founder of Roivant Sciences, Inc. (NASDAQ:ROIV), has seen his company's stock rise since announcing his candidacy. A $1,000 investment in Roivant when Ramaswamy announced his candidacy would have yielded a 30% return in six months. This compares to a 9.5% gain by the S&P 500 Index and a nearly 6% drop by the SPDR S&P Biotech ETF (NYSE:XBI). Roivant's subsidiaries include publicly listed Immunovant, Inc. (NASDAQ:IMVT).

Portfolio Pulse from Shanthi Rexaline

August 25, 2023 | 12:07 pm

VTAK

Catheter Precision has received a notice from NYSE American regarding the late filing of its quarterly report on Form 10-Q. The company is expected to submit the report soon to avoid any potential penalties.

Portfolio Pulse from Benzinga Newsdesk

August 25, 2023 | 12:05 pm

FBRX

Camac Partners and ATG Capital Management, who collectively own about 8.5% stake in Forte Biosciences, have filed a definitive proxy statement in connection with Forte's 2023 annual meeting scheduled for September 19.

Portfolio Pulse from Benzinga Newsdesk

August 25, 2023 | 12:04 pm

BJDX

Bluejay Diagnostics has announced a registered direct offering priced at-the-market under Nasdaq rules, amounting to $1.59M.

Portfolio Pulse from Benzinga Newsdesk

August 25, 2023 | 12:02 pm